Abstract:
PURPOSE: A composition for preventing or treating hyperlipidemia or obesity, which contains extract of Morus alba L. leaves is provided to reduce the content of total blood cholesterol, triglyceride, LDL-cholesterol, weight, lipid and blood leptin. CONSTITUTION: A pharmaceutical composition for preventing and treating hyperlipidermia or obesity contains extract of Morus alba L. leaves as an active ingredient. The extract is isolated using water including purified water, low alcohol of 1-4 carbon atoms or their mixture solvent.
Abstract:
PURPOSE: A composition containing Statholobi Caulis extract is provided to reduce H4IIE cytotoxicity induced by cadmium and to protect liver. CONSTITUTION: A pharmaceutical composition for preventing and treating liver disease contains Statholobi Caulis extract as an active ingredient. The Statholobi Caulis extract is a soluble in water including purified water, low alcohol of C1-C4, or mixture solvent thereof. A health food for preventing and treating alcoholic liver diseases contains Statholobi Caulis extract as an active ingredient. The health food is used in the form of powder, granule, tablet, capsule, or beverage.
Abstract:
PURPOSE: A processing method of glycyrrhizae radix having the increased content of liquiritigenin is provided to secure an optimal analysis condition for the liquiritigenin from a glycyrrhizae radix extract. CONSTITUTION: A processing method of glycyrrhizae radix having the increased content of liquiritigenin comprises the following steps: processing the glycyrrhizae radix by heating at 150-400 deg C for 1-20 minutes, by acidifying using a weak acid and alcohol mixed solution, or by combining both processes regardless of the order; extracting the glycyrrhizae radix at 0-100 deg C for 1-10 hours using a maceration extraction method, a hot water extraction method, an ultrasonic extraction method, a reflux cooling extraction method, or a heating extraction method for 1-7 times; and filtering and decompress-concentrating the extract to obtain a glycyrrhizae radix extract.
Abstract:
본 발명은 약효가 증강된 현호색 추출물, 그 제조방법 및 그를 함유하는 항균용 조성물에 관한 것으로, 상세하게는 본 발명의 제조방법에 의해 수득된 현호색 추출물은 유효성분인 디하이드로코리달린(dehydrocorydaline)의 함량이 증강되어 여드름의 원인균인 P.
acnes ( Propionibacterium
acnes ) 및 충치의 원인균인 S. mutans ( Streptococci mutans )에 대한 증진된 항균 활성을 가지고 있으므로, 충치 및 여드름의 예방 및 치료에 유용하게 이용될 수 있다. 현호색, 디하이드로코리달린, 충치, 여드름
Abstract:
A composition for improving and treating acne vulgaris, which contains Corydalis turtschaninovii extract or dehydrocorydaline is provided to have antibacterial effect against propionibacterium acnes. A pharmaceutical composition of skin external preparation for improving and treating acne vulgaris comprises 0.1-50 weight% of Corydalis turtschaninovii extract or dehydrocorydaline as an active ingredient. The Corydalis turtschaninovii extract is isolated from stem, leaf, and flower of Corydalis Tuber using one or more solvent selected from water, ethanol, methanol, propanol, butanol, acetone, ethylacetate, hexane, butylenes glycol, propylene glycol and hydrous butylenes glycol, hydrous propylene glycol and hydrous glycerin. The composition is used in a form of cream, gel, patch, ointment, lotion, or cataplasma agent.